Showing results (181-190 of 279) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generationAnnelie E Abrahamsson, Ifat Geron, Jason Gotlib, et al.
The New England Journal of Medicine|February 21, 2024
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia VeraMarina Kremyanskaya, Andrew T Kuykendall, Naveen Pemmaraju, et al.
Blood Advances|May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosisAaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trialRuben A Mesa, Jason Gotlib, Vikas Gupta, et al.
Gynecologic Oncology|March 8, 2025
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG studyVictoria L Bae-Jump, Michael W Sill, Paola A Gehrig, et al.
Blood|January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosisJason Gotlib, Animesh Pardanani, Cem Akin, et al.
Leukemia Research|July 25, 2025
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control studyAndreas Reiter, Jason Gotlib, Iván Álvarez-Twose, et al.
Expert Review of Hematology|April 6, 2012
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldPeter Valent, Gerald J Gleich, Andreas Reiter, et al.
Leukemia|March 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeDonal P McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Nature Medicine|December 7, 2021
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trialDaniel J DeAngelo, Deepti H Radia, Tracy I George, et al.
Pageof 28